
Ellen DeGeneres reveals Trump's re-election led to UK move
Speaking at the Everyman Theatre in Cheltenham, the former talk show host shared that life in the UK feels 'simpler and better,' praising the polite culture, treatment of animals, and overall charm of the British countryside.
DeGeneres, known for her long-running daytime show and voice work in Finding Nemo, admitted that political and social shifts in the U.S. were key factors in their decision. With movements attempting to roll back gay marriage rights, the couple is now considering renewing their vows in England.
She also addressed her career-ending controversy regarding workplace toxicity on The Ellen DeGeneres Show, which concluded in 2022. While acknowledging that she is 'blunt,' Ellen dismissed the allegations as 'clickbait,' expressing frustration at being labeled 'mean.'
The 67-year-old entertainer reflected on her legacy as one of the first openly gay TV stars, noting that while progress has been made, many celebrities still hide their sexuality. She praised younger generations for being more open and fluid, offering hope for greater acceptance.
Though she misses her show, Ellen isn't planning a return just yet—but hinted she'd 'love' to do a British talk show in the future. For now, she's enjoying farm life with chickens and simpler days in rural England.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Express Tribune
7 hours ago
- Express Tribune
Ellen DeGeneres eyes talk show comeback from England
Ellen DeGeneres may be done with American daytime television, but she's not done talking. During a live event in Gloucestershire, England, the 67-year-old comedian revealed she's open to returning to talk show hosting, this time from across the Atlantic. 'I would love to do that again,' Ellen told broadcaster Richard Bacon, when asked if she'd ever consider launching another show. 'But I just feel like people are watching on their phones, or people aren't really paying attention as much to televisions, because we're so inundated with information and entertainment.' It's been three years since The Ellen DeGeneres Show signed off after a 19-year run marked by both accolades and controversy. Since then, Ellen has kept a low profile, making headlines mostly for her quiet relocation to the Cotswolds in the U.K. with wife Portia de Rossi. What was originally intended as a part-time overseas retreat became a permanent move following Donald Trump's re-election. Ellen joked that the shift to rural English life included sheep that stayed for 'about two weeks' and seeing snow 'for the first time in my life'. Despite embracing the countryside and tending to chickens, Ellen hinted at creative restlessness. 'I want to have fun; I want to do something. I do like my chickens but I'm a little bit bored,' she admitted. Still, she said she's taking her next step 'very carefully' and has yet to decide what exactly that will look like. While a British talk show isn't confirmed, her comments suggest she's looking for something fresh, possibly reimagining what daytime TV could be in the streaming age. Whether it's another traditional series or something entirely unexpected, Ellen's next act may be closer than fans think.


Business Recorder
12 hours ago
- Business Recorder
AstraZeneca says to invest $50bn in the US
LONDON: British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington. A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030. 'Today's announcement underpins our belief in America's innovation in biopharmaceuticals,' the statement quoted CEO Pascal Soriot as saying. US President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which have so far benefited from exemptions to his sweeping levies on imports from trading partners. He ordered an investigation launched into pharmaceutical imports, suggesting that levies could reach up to 200 percent. AstraZeneca to buy EsoBiotec for up to $1 billion The United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States. 'For decades Americans have been reliant on foreign supply of key pharmaceutical products,' US Commerce Secretary Howard Lutnick said in a statement. He added that the new tariffs are focused on 'ending this structural weakness'. The announcement included a new factory in Virginia, which will be the company's 'largest single manufacturing investment'. Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have, in recent months, begun shifting investment and production to the United States.


Express Tribune
a day ago
- Express Tribune
Iran threatens to halt Gulf security if E3 reinstates UN sanctions
Iran could withhold security commitments if European states invoke a U.N. mechanism to reimpose international sanctions on the Islamic Republic, a member of Iran's parliamentary national security commission said on Monday, according to Borna news. "We have many tools at our disposal. We can withhold our commitment to security in the region, Persian Gulf and Hormuz Strait as well as other maritime areas," Abbas Moqtadaei said about Tehran's potential counter-measures to the reimposition of international sanctions. He was speaking ahead of a meeting on Friday between Iranian deputy foreign ministers and British, French and German diplomats in Istanbul. The three European states, known as E3, have said they would restore international sanctions on Iran by the end of August if the country did not enter productive talks on its nuclear programme with Western powers, notably the United States. E3 countries and Iran have in recent months held inconclusive talks on Tehran's nuclear program, in parallel to indirect nuclear negotiations between Tehran and Washington. Israel's attack on Iran in June led to the suspension of such talks. "Europe is not in a position to endanger itself in the... Hormuz Strait, when it is itself in political, economic and cultural conflicts with Russia, China and even the United States," Moqtadaei said in an interview with Iran's semi-official Borna news agency. Last week, Iran's foreign ministry spokesperson said Tehran would react to the three European states if they invoked the UN snapback mechanism, which expires on October 18. In a letter to the UN Secretary-General, Iranian Foreign Minister Abbas Araqchi said on Sunday that the E3 lacks the legal standing to invoke the mechanism, arguing that their stance on Israeli and US strikes on Iran's nuclear facilities last month made them no longer participants in the 2015 nuclear deal to which the snapback mechanism is linked. The three European countries, along with China and Russia, are the remaining parties to the nuclear pact - from which the U.S. withdrew in 2018 - that lifted sanctions on Iran in return for restrictions on its nuclear programme. In the past, Iran has used the threat of disrupting maritime transit in the Strait of Hormuz or no longer stopping Europe-bound drug trafficking as a means to push back against Western pressures on its nuclear programme.